Featured Article

5 minutes with… Andrew Cooper, CEO, CluePoints

Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven culture and what it takes to lead with innovation and teamwork
Guide

A Comprehensive Guide to Adaptive Site Monitoring

Download
Blog
ICH E6(R3), Demystified Part 2 | Defining Critical-to-Quality
  • Ethical and Actionable Trial Outcomes ICH E6(R3) is more than just an update to Good Clinical...
Read More
Press Release
CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth
  • King of Prussia, PA – January 12, 2026 – CluePoints, provider of leading statistical and AI-driven...
Read More
Blog
ICH E6(R3), Demystified: Turning Guidance into Oversight | Part 1
  • The New Era of Good Clinical Practice: A Practical Guide for Sponsors and CROs The updated...
Read More